Clinical Trial Update: BPC 157 for Acute Hamstring Muscle Strain Repair [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating BPC-157 for repairing acute hamstring muscle strain, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hamstring Muscle Strain
• Skeletal Muscle Injury

Drugs mentioned

• BPC-157 (pentadecapeptide BPC-157)

Snippet

Sponsor: Hudson Biotech | Conditions: Hamstring Muscle Strain, Skeletal Muscle Injury | Phase 2 | Status: RECRUITING